<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10</volume><submitter>Romaldini A</submitter><pubmed_abstract>The impact of graphene oxide on hepatic functional cells represents a crucial evaluation step for its potential application in nanomedicine. Primary human hepatocytes are the gold standard for studying drug toxicity and metabolism; however, current technical limitations may slow down the large-scale diffusion of this cellular tool for &lt;i>in vitro&lt;/i> investigations. To assess the potential hepatotoxicity of graphene oxide, we propose an alternative cell model, the second-generation upcyte&lt;sup>®&lt;/sup> hepatocytes, which show metabolic and functional profiles akin to primary human hepatocytes. Cells were acutely exposed to sub-lethal concentrations of graphene oxide (≤80 μg/ml) for 24 h and stress-related cell responses (such as apoptosis, oxidative stress, and inflammatory response) were ev</pubmed_abstract><journal>Frontiers in bioengineering and biotechnology</journal><pagination>867728</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9161028</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Sub-Lethal Concentrations of Graphene Oxide Trigger Acute-Phase Response and Impairment of Phase-I Xenobiotic Metabolism in Upcyte&lt;sup>®&lt;/sup> Hepatocytes.</pubmed_title><pmcid>PMC9161028</pmcid><pubmed_authors>Sabella S</pubmed_authors><pubmed_authors>Romaldini A</pubmed_authors><pubmed_authors>Poggi A</pubmed_authors><pubmed_authors>Catalano F</pubmed_authors><pubmed_authors>Spano R</pubmed_authors><pubmed_authors>Villa F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Sub-Lethal Concentrations of Graphene Oxide Trigger Acute-Phase Response and Impairment of Phase-I Xenobiotic Metabolism in Upcyte&lt;sup>®&lt;/sup> Hepatocytes.</name><description>The impact of graphene oxide on hepatic functional cells represents a crucial evaluation step for its potential application in nanomedicine. Primary human hepatocytes are the gold standard for studying drug toxicity and metabolism; however, current technical limitations may slow down the large-scale diffusion of this cellular tool for &lt;i>in vitro&lt;/i> investigations. To assess the potential hepatotoxicity of graphene oxide, we propose an alternative cell model, the second-generation upcyte&lt;sup>®&lt;/sup> hepatocytes, which show metabolic and functional profiles akin to primary human hepatocytes. Cells were acutely exposed to sub-lethal concentrations of graphene oxide (≤80 μg/ml) for 24 h and stress-related cell responses (such as apoptosis, oxidative stress, and inflammatory response) were ev</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-04T19:06:42.315Z</modification><creation>2024-11-13T05:15:22.642Z</creation></dates><accession>S-EPMC9161028</accession><cross_references><pubmed>35662849</pubmed><doi>10.3389/fbioe.2022.867728</doi></cross_references></HashMap>